coronavirus (covid-19) disease. COVID-19 Disease
Conditions
Interventions
Intervention 1: Intervention group: Two curcumin-piperine capsules (500 mg of curcumin + 5 mg of piperine) will be given daily for 2 weeks after lunch and dinner. Intervention 2: Control group: 2 plac
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Tendency to participate in the study People aged 18-65 years Diagnosis of Covid-19 based on the PCR test
Exclusion criteria
Exclusion criteria: Age less than 20 and more than 75 years Taking warfarin Sensitivity to herbal products such as turmeric and pepper
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT of the chest. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Find out - Photos - CT.;Body temperature. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: By using clinical thermometer.;Duration of hospitalization. Timepoint: At the time of discharge from the hospital. Method of measurement: By Using the patient's medical record.;Hs-CRP. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Enzymatic method.;ESR. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Enzymatic method.;ALT. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Enzymatic photometric method.;AST. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Enzymatic photometric method.;LDH. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Enzymatic photometric method.;BUN. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: urine sample.;Creatinine. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: by laboratory kit.;CBC. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: blood sample.;Blood oxidative stress indices ( SOD, MDA, TAC). Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: By using available commercial kits.;Albumin. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: blood sample.;Severity of the disease. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: By using clinical and laboratory evaluations.;Severity and number of coughs. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Visual analogue scales (VAS) for cough. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamreza Askari
Esfahan University of Medical Sciences
Outcome results
None listed